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Primers were used to amplify a 561-bp region of the 16S rRNA gene of Ehrlichia phagocytophila from Ixodes
scapularis ticks and small mammals collected in Rhode Island and Connecticut. DNA sequences for all 50 E.
phagocytophila-positive samples collected from 1996 through 1998 in southwestern Connecticut were identi-
cal to the sequence reported for E. phagocytophila DNA from confirmed human cases. In contrast, the
sequences from 92 of 123 E. phagocytophila-positive Rhode Island samples collected from 1996 through
1999 included several variants differing by 1-2 nucleotides from that in the agent infecting humans. While
11.9% of 67 E. phagocytophila-positive ticks collected during 1997 in Rhode Island harbored ehrlichiae with
sequences identical to that of the human agent, 79.1% had a variant sequence not previously described. The
low incidence of human ehrlichiosis in Rhode Island may in part result from these variant ehrlichiae’s  interfer-
ence with the maintenance and transmission of the true agent of human disease.
embers of the genus Ehrlichia are obligate, intracellular
bacteria in the order Rickettsiales. Although ehrlichial
infections of veterinary importance were first described in
1935, the first case of human ehrlichiosis in the United States
was reported in 1987 (1). The human pathogen was subse-
quently identified as Ehrlichia chaffeensis (2), and the number
of reported human cases now exceeds 740 (3). In 1994, a sec-
ond ehrlichial infection in humans was reported, called human
granulocytic ehrlichiosis (HGE) because of its proclivity to
infect neutrophils (4). Most HGE cases have been diagnosed
in the northeastern and upper midwestern United States,
although a few cases have been reported in Europe and north-
ern California (5-12). 
The close genetic and antigenic relationship of the HGE
agent to two previously characterized species (E. phagocyto-
phila, noted for infections of ruminants in Europe, and E. equi,
the agent of equine granulocytic ehrlichiosis) has led to the
suggestion that these three be classified as a single species,
with E. phagocytophila as the precedent name. The 16S rRNA
gene has been amplified and sequenced from confirmed
human cases in both North America and Europe, and all
sequences have been identical to the original published
sequence for the HGE agent (4,8), with the exception of two
cases recently reported from northern California that were the
same as the E. equi 16S rRNA gene sequence (12). A variant
that differed by 2 bp from the sequence of the HGE agent was
reported in white-tailed deer in Maryland and Wisconsin and
in Ixodes scapularis ticks collected in Rhode Island (13,14).
Likewise, the 16S rRNA sequences determined from docu-
mented infections of horses and ruminants by various E.
phagocytophila strains have differed by several bp from the
sequences of the HGE agent. None of the variant forms have
been shown to cause human disease. Another ehrlichia found
in nature, which is closely related to E. phagocytophila but
apparently does not cause human disease, is the white-tailed
deer agent (15). Ehrlichiae closely related to E. phagocyto-
phila recently have been identified in Colorado, where human
ehrlichiosis is not endemic (16). These data suggest that only a
subset of the E. phagocytophila strains that exist in nature can
cause human disease. Although the HGE agent is now consid-
ered a member of the species E. phagocytophila, hereafter we
will designate the isolates responsible for human disease as E.
phagocytophila-human agent (EP-ha) to differentiate them
from the 16S rRNA sequence variants we describe in this
report. 
Rhode Island and Connecticut, adjacent northeastern
states, have similar frequency and distribution of vector I.
scapularis ticks and primary reservoir hosts (white-footed
mice and chipmunks) (17-19). However, the number of
reported human infections with E. phagocytophila is dramati-
cally higher in Connecticut than in Rhode Island. Through
1997, the average annual incidences (per one million popula-
tion) of HGE in Connecticut and Rhode Island were 15.90 and
0.67, respectively (3). We investigated the frequency and dis-
tribution of E. phagocytophila, including EP-ha and E. phago-
cytophila-related variants, in potential reservoir and vector
populations in Rhode Island and Connecticut.
M
1Since this study was conducted, new nomenclature (Anaplasma
phagocytophila) has been proposed; see Dumler JS, Barbet AF, Bekker
CP, Dasch GA, Palmer GH, Ray SC, et al. Reorganization of genera in
the families Rickettsiaceae and Anaplasmataceae in the order Rickett-
siales: unification of some species of Ehrlichia with Anaplasma, Cow-
dria with Ehrlichia, and Ehrlichia with Neorickettsia, descriptions of six
new species combinations and designation of Ehrlichia equi and ‘HGE
agent’ as subjective synonyms of Ehrlichia phagocytophila. Int J Syst
Evol Microbiol 2001;51:2145-65.
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Materials and Methods
Tick and Mammal Collections
Questing nymphal and adult black-legged ticks (I. scapu-
laris) collected from four sites in South Kingstown, Rhode
Island, and one site in Bridgeport, Connecticut, were analyzed
for the presence of granulocytic ehrlichiae (Figure). Collec-
tions of adult- or nymphal-stage ticks or both were available
from ongoing tick surveillance conducted in each region from
1996 to 1999. Questing nymphal ticks collected from Bluff
Point in southeastern Connecticut in 1997 were also available.
The Rhode Island sites are all located in the state’s zone of
highest I. scapularis density (17). Tick density was also high
at the Bridgeport site. Ticks were collected by following stan-
dardized sampling procedures (17). All ticks were stored for
<2 years in 70% ethanol until tested. Small rodents, including
white-footed mice (Peromyscus leucopus) and chipmunks
(Tamias striatus) live-trapped at the same locations were bled
following procedures approved by the institutional animal care
and use committees of each institution. Briefly, animals were
trapped from July to September along transect lines or in trap-
ping grids. An additional collection was made during May
1998 at the Bridgeport site. Blood was stored in EDTA at
-80°C until tested for ehrlichiae by polymerase chain reaction
(PCR) techniques and DNA sequencing. 
Sample Preparation
DNA was extracted directly from blood samples by using a
QIAamp Blood Extraction Kit (Qiagen, Chatsworth, CA),
according to manufacturer’s instructions. Briefly, detergent
lysis was done in the presence of proteinase K for 10 min at
70°C. The lysed material was applied to a spin column con-
taining a silica gel-based membrane and then washed twice.
Purified DNA was eluted from the columns in 200 µL Tris-
HCl (10 mM, pH 8.0) and stored at 4°C until used as template
for PCR amplification. DNA was extracted from I. scapularis
ticks by a modification of the manufacturer’s protocol for the
QIAamp Tissue Kit (Qiagen) as described (13). 
PCR Analysis
A nested PCR that amplified a 546-bp portion from the 5´
region of the 16S rRNA gene was used to identify granulocytic
ehrlichiae in tick and wildlife samples (13). Briefly, primary
amplifications consisted of 40 cycles in a Perkin-Elmer 9600
thermal cycler (Perkin-Elmer, Applied Biosystems Division,
Foster City, CA), with each cycle consisting of a 30-sec dena-
turation at 94°C, 30-sec annealing at 55°C, and a 1-min exten-
sion at 72°C. The 40 cycles were preceded by a 2-minute
denaturation at 95°C and followed by a 5-minute extension at
72°C. Primary amplifications used primers ge3a and ge10r and
reagents from the GeneAmp PCR Kit with AmpliTaq DNA
Polymerase (Perkin-Elmer). Each reaction contained 5 µL of
purified DNA as template in a total volume of 50 µL, as well
as 200 µM each deoxynucleoside triphosphate (dNTP) (dATP,
dCTP, dGTP, and dTTP), 1.25 units Taq polymerase, and
0.5 µM each of primer. Reaction products were subsequently
maintained at 4°C until analyzed by agarose gel electrophore-
sis or used as template for nested reactions.
Nested amplifications used primers ge9f and ge2 and 1 µL
of the primary PCR product as template in a total volume of 50
µl. Each nested amplification contained 200 µM each dNTP
(dATP, dCTP, dGTP, and dTTP), 1.25 units Taq polymerase,
and 0.2 µM each of primer. Nested cycling conditions were as
described for the primary amplification, except 30 cycles were
used. Reactions were subsequently maintained at 4°C until
analyzed by agarose gel electrophoresis or purified for DNA
sequencing (13).
DNA Sequencing and Data Analysis
All samples producing positive PCR products were sub-
jected to DNA sequencing reactions with fluorescent-labeled
dideoxynucleotide technology (Dye Terminator Cycle Sequenc-
ing Ready Reaction Kit, Perkin-Elmer, Applied Biosystems
Division). Sequencing reaction products were separated, and
data were collected with an ABI 377 automated DNA sequencer
(Perkin-Elmer, Applied Biosystems Division). The full
sequence was determined for both strands of each DNA tem-
plate to ensure maximum accuracy of the data. Sequences were
edited and assembled with the Staden software programs (20)
and analyzed with the Wisconsin Sequence Analysis Package
(Genetics Computer Group, Madison, WI) (21). 
Results
Fifty (13.3%) of 375 I. scapularis ticks from Bridgeport,
Conn., were PCR positive for ehrlichiae (Table 1). The per-
centage positive in each of the 4 years ranged from 6.1% in
nymphs in 1998 to 23.3% in adults in 1996. Less year-to-year
variation was noted in adult ticks, in which infection preva-
lence ranged from 11.7% (1997) to 23.3% (1996). PCR analy-
sis of EDTA blood samples from white-footed mice collected
Figure. Map of northeastern United States, showing location of tick and
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in Connecticut during summer and fall 1997 and spring 1998
showed that 17 (36.2%) of 47 in 1997 and 3 (60%) of 5 in
1998 were positive (22). The amplification products were
sequenced for each Ehrlichia PCR-positive mouse and tick.
All products from samples collected in the Bridgeport, Conn.,
area from 1996 through 1998 had sequences identical to the
16S rRNA gene (EP-ha) previously amplified and sequenced
from documented human infections in the Northeast and
Upper Midwest United States and in Europe (4). The 16S
rRNA sequence determined from adult ticks collected from
Bridgeport in 1999 showed that all 12 positive samples also
contained the human agent (EP-ha), although one of the ticks
produced a mixed sequence, suggesting the presence of more
than one agent. The PCR products from this tick were cloned,
and individual clones were purified and sequenced. These data
confirmed the presence of a mixed population of ehrlichiae
containing some 16S rRNA sequences that matched EP-ha and
some that differed from EP-ha by two nucleotides. The latter
sequence was identical to a variant (called variant 1) previ-
ously described in ticks in Rhode Island and deer in Maryland
and Wisconsin (13,14) (Table 2). In contrast to ticks and
rodents from the Bridgeport area, nymphal ticks collected in
1997 from Bluff Point in southeastern Connecticut contained a
nearly equal distribution of EP-ha (5 [55.6%] of 9 positives)
and variant 1 (4 [44.4%] of 9 positives) ehrlichiae.
Rhode Island samples from I. scapularis ticks, white-footed
mice, and chipmunks contained E. phagocytophila variants as
well as EP-ha. A total of 123 (22.9%) of 538 ticks were posi-
tive for E. phagocytophila by PCR, including 61 (26.3%) of
232 adults and 62 (20.3%) of 306 nymphs. DNA sequencing
was performed on 92 of these PCR products, and overall, only
24 (26.1%) showed sequences identical to those of EP-ha. Fif-
teen (16.3%) ticks showed sequences corresponding to variant
1. The rest of the ticks (53 [57.6%]) had a novel sequence dif-
fering from EP-ha by two nucleotides and from variant 1 by
four nucleotides (hereafter called variant 2) (Table 2). 
PCR testing of blood samples from 19 Rhode Island chip-
munks in 1996 detected 11 (57.9%) positives. DNA sequenc-
ing of these PCR products showed that nine were identical to
the sequence of EP-ha; the remaining two represented novel
variant sequences, each differing from EP-ha by a single
nucleotide (variants 3 and 4; Table 2). Although both the
white-tailed deer agent and the E. equi/CA human sequence
variant (Table 2) are amplified by the PCR assay used in this
study, neither agent has been detected in potential rodent reser-
voir populations in Connecticut or Rhode Island. Host and
vector associations of EP-ha and the four E. phagocytophila
variants found in Rhode Island are shown in Table 3.
The prevalence of E. phagocytophila in I. scapularis ticks
(adults and nymphs combined, years 1996-1999) was higher in
Rhode Island (22.8%) than in Bridgeport (13.3%) (p<0.001;
Fisher’s exact test). This finding was also true for adult ticks:
26.3% were infected in Rhode Island compared with 15.4% in
Table 1. Spatial and temporal variation in the occurrence and distribution of Ehrlichia phagocytophila-human agent (EP-ha) and E. phagocytophila 
variants, Connecticut and Rhode Island, 1996–1999
Collection site Year No. Adult Nymph
No. of PCR-
positive ticks (%)
No. of PCR
 products sequenced
%Proportion infected with—
EP-ha  Variant 1 Variant 2
Bridgeport, CT  1996 30 + 7 (23.3) 7 100
1997 60 + 7 (11.7) 7 100
1998 82 + 5 (6.1) 5 100
1998 101 + 19 (18.8) 19 100
1999 102 + 12 (11.8) 12 100a 8.3a
Bluff Point, CT 1997 79 + 9 (11.4) 9 55.6 44.4
South Kingstown, RI 1996 31 + 5 (16.1) 5 60 40
1997 112 + 52 (46.4) 30 10 3.3 86.7
1997 120 + 46 (38.3) 37 13.5 13.5 73
1998 91 + 5 (5.5) 5 20 80
1999 103 + 5 (4.9) 5 80 20
1999 81 + 10 (12.3) 10 80 20
 aIncludes one tick that was positive for both the human granulocytic ehrlichiosis agent and variant 1.
PCR,  polymerase chain reaction.
Table 2. Variation within nucleotide region 74 to 446 in 16s rRNA gene 
sequences obtained for Ehrlichia phagocytophila-human agent (EP-
ha),a the Rhode Island variants, and E. equi 
Position no.
76 84 157 176 284 299
EP-ha A G A G C A
RI variant 1 Gb A AGCA
RI variant 2 A G A ATA
RI variant 3 A G G GCA
RI variant 4 A G A G C G
E. equi/CA human A A AGCA
a The number designations for the EP-ha 16S rDNA sequence correspond to those 
reported by Chen et al. (4). GenBank accession no. U02521.
b Variant base pairs are shown in bold.RESEARCH
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Bridgeport (p=0.002). Using either the total number of ticks
tested or adult ticks only, the prevalence of E. phagocytophila
in Rhode Island compared with Bridgeport was 1.7. However,
if the 1997 Rhode Island data, which were skewed by an
unusually large number of variants, are removed from the cal-
culations, the percentage of E. phagocytophila-positive ticks
(adults and nymphs) was significantly higher in Bridgeport
(13.3%) than in Rhode Island (8.2%) (p=0.03). The same anal-
ysis, when restricted to the adult tick population, showed no
significant difference between Connecticut (15.4%) and
Rhode Island (13.4%) EP-positive ticks (p=0.6). If the 1997
Rhode Island data are excluded, the prevalence of E. phagocy-
tophila in that state compared with Bridgeport was 0.6 for the
total number of ticks tested and 0.8 for adult ticks only. 
Infection prevalence data were available for adult and
nymphal ticks from the same site for 3 years: Rhode Island in
1997 and 1999 and Bridgeport in 1998 (Table 1). For two of
these, Rhode Island in 1999 and Bridgeport in 1998, the preva-
lence of E. phagocytophila was significantly higher (Rhode
Island 1999; p=0.01) or borderline higher (Connecticut 1998;
p=0.065) in adults than in nymphs. E. phagocytophila infec-
tion rates in nymphal and adult ticks from Rhode Island in
1997 did not differ significantly (p=0.21). 
Temporal trends in tick infection rates showed that the
prevalence of E. phagocytophila in Rhode Island nymphs was
highest in 1997 and then declined in 1998 and 1999 (p<0.001;
chi-square test for trend). However, the high number of vari-
ants found in both adult and nymphal ticks from Rhode Island
in 1997 influenced this analysis, as E. phagocytophila preva-
lence in Rhode Island in 1997 was significantly higher than in
all other years combined (p<0.001). In Bridgeport, no signifi-
cant temporal trends were noted in E. phagocytophila infec-
tion rates in adult ticks (p=0.3), nor were significant
prevalence or temporal trends noted in the rodents tested from
any of the sites.
Analysis of the proportion of E. phagocytophila-positives
that were variants showed that prevalence of the variants in
Rhode Island (73.9% variants) was significantly higher than in
Bridgeport (0.02% variants) (p<0.001). When the proportion
of E. phagocytophila-positives that were variants was com-
pared with the total number of positives for the two Connecti-
cut sites, the ticks from Bluff Point (44.4% variants) showed
significantly higher rates than ticks from Bridgeport (0.02%
variants) (p<0.001).
Discussion
Strains of E. phagocytophila found in nature are capable of
causing disease in sheep, cattle, horses, dogs, cats, and
humans. These strains, including the species previously known
as the HGE agent and E. equi, are grouped as a single species
on the basis of their close relationship at the genetic and anti-
genic levels. However, biological and ecological differences
clearly exist between strains of E. phagocytophila, including
varying host pathogenicity, vectors, DNA sequence, and geo-
graphic distribution. Small ribosomal subunit (16S) DNA
sequences are highly conserved in bacteria and are often used
to identify and differentiate bacterial species. The 16S rRNA
gene sequences amplified from every confirmed human case,
except for two isolated cases in northern California, have been
identical to the E. phagocytophila-human agent (EP-ha)
sequence determined by Chen et al. (4). PCR-positive white-
footed mice (n=20) and I. scapularis ticks (n=38) collected in
Bridgeport from 1996 through 1998 also harbored only E.
phagocytophila identical in sequence to EP-ha for a 546-bp
region of the 16S rRNA gene (4). Sequence analysis of PCR
products from two Connecticut deer blood samples showed
DNA identical to the EP-ha p44 gene sequence (23). However,
an Ehrlichia organism with a 16S rRNA gene sequence differ-
ing from EP-ha by a single nucleotide has been identified in
white-tailed deer from Maryland and Wisconsin and in I. scap-
ularis from Rhode Island (13,14).
In contrast to our results from Bridgeport, where we con-
sistently found EP-ha, mice and ticks from Rhode Island had a
significantly lower percentage of isolates identical to EP-ha,
but several E. phagocytophila variants with novel 16S rRNA
gene sequences. These data indicate that variant forms of E.
phagocytophila, not yet associated with human or veterinary
disease, frequently occur in Rhode Island. The same or addi-
tional  E. phagocytophila variants may also occur in other
regions of the United States, but this concept remains to be
investigated. 
Most PCR assays amplify products from the variant agents
that are the same size as the EP-ha PCR product, so that vari-
ants are indistinguishable when the products are analyzed only
by agarose gel electrophoresis. Therefore, results from other
human-infection prevalence surveillance studies in ticks and
rodents that have not included PCR product sequencing may
be misleading. For example, if we had not sequenced our PCR
products for 1997, we would have concluded that 46.4% of
nymphal and 38.3% of adult I. scapularis ticks collected in
southern Rhode Island were positive for EP-ha. Actually, only
11.9% of the positives that were sequenced and an estimated
5.0% of the total ticks tested were EP-ha positive, with the rest
of the 1997 Rhode Island positives consisting of genetic vari-
ants not yet associated with human disease. 
The 16S rRNA sequences obtained from tick and rodent
samples collected from Bridgeport from 1996 through 1998
Table 3. Host and vector associations of Ehrlichia phagocytophila 
and the four 16S rDNA sequence variants detected in Rhode 
Island,1996–1999
Host or tick species EP-ha  Variant 1a Variant 2 Variant 3 Variant 4
Ixodes scapularis ticks + + + – –
White-footed mouse + – + – –
Eastern chipmunk + – – + +
White-tailed deer  –+–––
Humanb +– –––
aVariant 1 detected only in ticks in Rhode Island and Connecticut; positive deer samples 
were collected in Maryland and Wisconsin (13,14). 
bBased on samples from 35 confirmed human infections from various states, including 
Rhode Island and Connecticut.Emerging Infectious Diseases  •  Vol. 8, No. 5, May 2002 471
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were identical to EP-ha. However, in 1999, one tick collected
in that site was positive for both EP-ha and a variant (variant
1) previously found in Rhode Island. In a retrospective analy-
sis of ticks collected at another eastern Connecticut site (Bluff
Point) close to the Rhode Island border, variant 1 was found in
1997. Our inability to detect variant 1 despite extensive testing
of samples collected in Bridgeport from 1996 to 1998 and its
subsequent appearance in 1999 suggests that its geographic
range may be expanding westward. Additional studies with
larger sample sizes of ticks and rodents from Bridgeport and
other locations in Connecticut are needed to assess the preva-
lence of EP-ha and the variants, as our Bridgeport results may
not be representative of the entire state. In fact, the Bluff Point
data suggest that other areas of Connecticut may have EP-ha/
variant populations quite different from those in Bridgeport
and more similar to the distribution noted in Rhode Island. 
The identification of the coinfected tick in Connecticut
represents the first detection of more than one strain of E.
phagocytophila in a single tick vector in the United States,
although the coinfection of I. xodes ricinus ticks by E. phago-
cytophila strains has been reported in Europe (24). These data
indicate that two strains of the agent are capable of coexisting
in a single tick, at least transiently, and that they can survive
the molting process, since the coinfection was found in an
unfed, host-seeking adult tick. 
The results from Rhode Island samples collected in 1997
are unusual in several regards. First, the rate of E. phagocyto-
phila-positive ticks (42.2% nymphs and adults) was very high
relative to all other tick populations sampled from 1996
through 1999, and many of the positives were variant 2 (79.1%
of PCR-positives sequenced). Second, the 1997 Rhode Island
ticks represent the only population in which E. phagocytophila
prevalence was higher in nymphs than adults (46.4% nymphs
and 38.3% adults). Finally, variant 2 sequences were also seen
in samples collected in 1997 from white-footed mice and chip-
munks but were not detected before and have not been
detected after 1997. The fact that both nymphal and adult
questing ticks were positive for variant 2 suggests that the
variant was present in reservoir species during both larval and
nymphal feedings and may have been present in reservoirs
from late summer 1996 through summer 1997. Why this vari-
ant appeared only in Rhode Island during 1997, was the most
prevalent strain infecting ticks that year, and then completely
disappeared are matters of speculation. Variant 2 may be a
more common infection in a reservoir species that we did not
examine, which may be less commonly targeted by host-seek-
ing ticks. Expression of variant 2 in the tick population could
have resulted if, during 1996-1997, host populations preferred
by immature I. scapularis (i.e., white-footed mice and chip-
munks) were lower than normal, resulting in a higher propor-
tion of ticks feeding on such atypical hosts harboring variant 2.
After molting, nymphs infected as larvae the previous year
could have transmitted variant 2 to the more preferred hosts of
immature ticks, resulting in the variant 2-positive mice found
in 1997. Subsequent reestablishment of normal host popula-
tions may then have diluted the prevalence of variant 2, as
immature tick feeding reverted to the preferred hosts.
Although the function and biological importance of the
genetic differences in E. phagocytophila strains are unknown,
we hypothesize that the variants may be interfering with main-
tenance and transmission of the human disease-causing agent
(EP-ha). Even if an increased human ehrlichiosis case surveil-
lance effort in Connecticut is taken into account, the number of
confirmed and suspected cases differs dramatically between
the two neighboring states: several hundred cases were
reported in Connecticut compared with fewer than 25 cases in
Rhode Island during the same time period. From 1995 to 1997,
178 cases were confirmed or suspected (25), and case reports
in Connecticut increased substantially in 1998 (228 provi-
sional, 104 confirmed, Connecticut Dept. of Public Health).
These adjacent states share many of the ecologic factors that
support natural maintenance of both Borrelia burgdorferi and
granulocytic ehrlichiae, such as populations of the tick vector
I. scapularis and reservoir rodents, including white-footed
mice (P. leucopus) (19,22). The incidence of Lyme disease in
Connecticut and Rhode Island has been the highest in the
nation for several years, with Connecticut having a reported
incidence only approximately 1.3-1.5 times higher than Rhode
Island’s (26). In contrast, through 1997 there was a 24-fold dif-
ference in the incidence of reported HGE cases in the two
states (Connecticut 15.9; Rhode Island 0.67). Therefore, the E.
phagocytophila variants may have a competitive advantage over
the EP-ha, possibly in infecting certain reservoir or vector popu-
lations. A lower incidence of EP-ha and less human disease
would therefore be expected in areas where the variants pre-
dominate, since a lower proportion of ticks would harbor EP-ha. 
Rickettsia rickettsii, the etiologic agent of Rocky Mountain
spotted fever, was first identified in the early 1900s on the
basis of its association with human disease (27). Subsequent
studies of veterinary infections and tick populations identified
numerous Rickettsia species closely related to R. rickettsii, all
clearly members of the spotted fever group but not associated
with human disease. These species include R. montana,  R.
rhiphicephali, R. parkeri, R. bellii, and the “east side agent” R.
peacockii (28,29). Nonpathogenic rickettsiae are thought to
interfere with the development of more virulent R. rickettsii in
Dermacentor ticks and may be found more often in ticks than
are the more virulent species (30,31). Our data suggest that a
similar situation may exist among the granulocytic ehrlichiae,
with both pathogenic and nonpathogenic genetic variants
coexisting in nature. Isolation of the new variants will allow us
to address this competitive-advantage hypothesis experimen-
tally in both ticks and mice through the use of mixed infections
in the laboratory.
Identification and use of novel gene targets more variable
than the 16S rRNA gene will eventually permit better
assessment of variability between strains of E. phagocytophila
(32-34). Future studies should include E. phagocytophila from
additional geographic areas where a substantial number of
human cases of granulocytic ehrlichiosis are reported (e.g., NewRESEARCH
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York, Wisconsin, Minnesota) compared with areas (e.g., New
Jersey, Pennsylvania, Delaware, Maryland, California) with
similar vector densities but with little or no human disease. 
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